Table 1. Enriched GO functions and KEGG pathways of differentially expressed coding RNAs.
| Category | Term | Count | P value |
|---|---|---|---|
| Biology Process | GO: 0009611∼response to wounding | 67 | 2.55E-13 |
| GO: 0006955∼immune response | 77 | 2.08E-12 | |
| GO: 0006954∼inflammatory response | 44 | 6.85E-10 | |
| GO: 0002684∼positive regulation of immune system process | 36 | 1.67E-09 | |
| GO: 0006952∼defense response | 64 | 3.54E-09 | |
| GO: 0050778∼positive regulation of immune response | 26 | 1.47E-08 | |
| GO: 0002252∼immune effector process | 23 | 2.63E-07 | |
| GO: 0045087∼innate immune response | 22 | 1.77E-06 | |
| GO: 0048584∼positive regulation of response to stimulus | 29 | 5.96E-06 | |
| GO: 0042060∼wound healing | 25 | 1.04E-05 | |
| GO: 0001775∼cell activation | 32 | 1.33E-05 | |
| GO: 0048534∼hemopoietic or lymphoid organ development | 30 | 1.36E-05 | |
| GO: 0030097∼hemopoiesis | 28 | 1.70E-05 | |
| GO: 0050865∼regulation of cell activation | 23 | 2.39E-05 | |
| GO: 0030029∼actin filament-based process | 28 | 2.49E-05 | |
| Cellular Component | GO: 0044459∼plasma membrane part | 155 | 2.53E-08 |
| GO: 0031093∼platelet alpha granule lumen | 13 | 2.00E-07 | |
| GO: 0005615∼extracellular space | 63 | 2.65E-07 | |
| GO: 0044421∼extracellular region part | 80 | 3.03E-07 | |
| GO: 0060205∼cytoplasmic membrane-bounded vesicle lumen | 13 | 4.71E-07 | |
| GO: 0031983∼vesicle lumen | 13 | 7.98E-07 | |
| GO: 0031091∼platelet alpha granule | 14 | 1.19E-06 | |
| GO: 0042611∼MHC protein complex | 14 | 1.48E-06 | |
| GO: 0005886∼plasma membrane | 226 | 3.93E-06 | |
| GO: 0005576∼extracellular region | 135 | 4.08E-06 | |
| GO: 0005887∼integral to plasma membrane | 89 | 5.27E-06 | |
| GO: 0031226∼intrinsic to plasma membrane | 90 | 7.08E-06 | |
| Molecular Function | GO: 0004857∼enzyme inhibitor activity | 35 | 1.04E-07 |
| GO: 0003779∼actin binding | 36 | 3.10E-06 | |
| GO: 0004866∼endopeptidase inhibitor activity | 22 | 3.18E-06 | |
| GO: 0030414∼peptidase inhibitor activity | 22 | 7.56E-06 | |
| GO: 0032395∼MHC class II receptor activity | 8 | 1.36E-05 | |
| KEGG Pathway | hsa04610: Complement and coagulation cascades | 18 | 2.04E-07 |
| hsa05330: Allograft rejection | 12 | 2.50E-06 | |
| hsa04514: Cell adhesion molecules (CAMs) | 22 | 1.69E-05 | |
| hsa04612: Antigen processing and presentation | 15 | 0.000189 | |
| hsa04810: Regulation of actin cytoskeleton | 23 | 0.004886 | |
| hsa04670: Leukocyte transendothelial migration | 15 | 0.00551 | |
| hsa04650: Natural killer cell mediated cytotoxicity | 16 | 0.006762 | |
| hsa04666: Fc gamma R-mediated phagocytosis | 12 | 0.013475 | |
| hsa04662: B cell receptor signaling pathway | 10 | 0.017701 | |
| hsa03320: PPAR signaling pathway | 9 | 0.027244 | |
| hsa04062: Chemokine signaling pathway | 18 | 0.028853 | |
| hsa04540: Gap junction | 10 | 0.043395 | |
| hsa04520: Adherens junction | 9 | 0.04559 | |
| hsa04142: Lysosome | 12 | 0.046965 | |
| hsa04510: Focal adhesion | 18 | 0.048777 |
GO: Gene Ontology.